Articles Referencing BAYRY
Bayer Files Riociguat in Japan - Analyst Blog
5/21/2013, 6:25 pm from Zacks.com in Investing, Business, Stocks
The HealthCare segment of Bayer ( BAYRY ) recently
submitted a regulatory application for its chronic thromboembolic
pulmonary hypertension (CTEPH) candidate, riociguat, in Japan. Bayer... Read >>
Yet Another Acquisition for Bayer - Analyst Blog
5/21/2013, 10:29 am from Zacks.com in Investing, Business, Stocks
Bayer ( BAYRY ) recently
inked a deal to acquire all shares of Germany-based Steigerwald
Arzneimittelwerk GmbH. Steigerwald Arzneimittelwerk is a private
pharmaceutical company which... Read >>
Bayer's Xofigo Cleared in the US - Analyst Blog
5/16/2013, 6:30 pm from Zacks.com in Investing, Business, Stocks
Bayer 's ( BAYRY ) HealthCare
segment recently received encouraging news as the US Food and Drug
Administration (FDA) approved its oncology drug Xofigo (radium 223
dichloride). Xofigo was... Read >>
Narrower Loss from Onyx, Guidance Maintained - Analyst Blog
5/8/2013, 6:25 pm from Zacks.com in Investing, Business, Stocks
Narrower Loss from Onyx, Guidance
Maintained Onyx Pharmaceuticals Inc. ( ONXX ) reported a loss
of 32 cents per share in the first quarter of 2013, well below the
Zacks Consensus... Read >>
Bayer Discontinues Hemophilia Study - Analyst Blog
5/6/2013, 5:23 pm from Zacks.com in Investing, Business, Stocks
Bayer 's ( BAYRY ) HealthCare
segment recently decided to discontinue the phase II/III TRUST
(TReatment with Unique recombinant rFVIIa STudy) study on BAY
86-6150. The study was evaluating... Read >>
Are These The Biotech Stars Of Tomorrow?
5/2/2013, 11:00 am from StreetAuthority in Investing, Investing Ideas, Stocks
In the past 30 years, hundreds of thousands of people have been
given a second chance after battling cancer. Many of these cancer
survivors have long been in remission, but there's still reason... Read >>
Bayer Aims to Expand HealthCare Portfolio - Analyst Blog
4/30/2013, 2:47 pm from Zacks.com in Investing, Business, Stocks
In a bid to strengthen its contraceptive portfolio
Bayer ( BAYRY ) inked a deal
to buy Conceptus Inc. ( CPTS ) for $31.00 per
share or approximately $1.1 billion in cash. Conceptus... Read >>
Conceptus Beats Earnings, Merger Announced - Analyst Blog
4/30/2013, 9:54 am from Zacks.com in Investing, Business, Earnings, Stocks
Contraception device maker, Conceptus Inc. ( CPTS ) reported
earnings per share (EPS) of 5 cents in the first quarter of 2013, a
massive improvement from a net loss of 9 cents per share in... Read >>
Bayer Earnings Rise Y/Y - Analyst Blog
4/26/2013, 4:21 pm from Zacks.com in Investing, Business, Earnings, Stocks
Bayer 's ( BAYRY ) earnings
during the first quarter of 2013 came in at €1.70 per share
(approx. $2.24) compared with €1.67 per share (approx. $2.19) in
the year-ago period. Earnings... Read >>
Favorable Court Ruling for Actavis - Analyst Blog
4/19/2013, 6:13 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
re-launched Vestura (3 mg drospirenone and 0.02 mg ethinyl
estradiol), the company's generic version of
Bayer's ( BAYRY ) oral
contraceptive, Yaz. Actavis... Read >>
Stock Upgrades: UPS Can Deliver for Investors
4/18/2013, 9:26 am from Minyanville in Investing, Stocks
Little wonder that toy titan Mattel (MAT), up
1.86% to finish at a fresh 52-week peak, bucked a brutal day in
equities. After all, yo-yos are suddenly all the rage on Wall
Street. The Dow ... Read >>
Priority Review for Bayer's Riociguat - Analyst Blog
4/9/2013, 4:08 pm from Zacks.com in Investing, Business, Stocks
Bayer 's ( BAYRY ) HealthCare
segment recently received encouraging news from the US Food and
Drug Administration (FDA) as it granted priority review designation
to the New Drug Application... Read >>
Data Presented on Bayer's ATX-101 - Analyst Blog
4/8/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
Bayer AG ( BAYRY ) recently
presented positive results on ATX-101 at the 11th Anti-Aging
Medicine World Congress (AMWC) 2013. ATX-101 is being developed for
the reduction of unwanted fat... Read >>
Regeneron Aims HQ Expansion - Analyst Blog
4/8/2013, 6:06 pm from Zacks.com in Investing, Business, Stocks
Regeneron Pharmaceuticals ( REGN ) announced
recently that it intends to expand its corporate headquarters and
laboratories in Westchester County, New York. The move is expected
to create... Read >>
Japanese Approval for Bayer's drug - Analyst Blog
3/27/2013, 2:25 pm from Zacks.com in Investing, Business, Stocks
Bayer 's ( BAYRY ) HealthCare
segment recently received encouraging news as the Ministry of
Health, Labour and Welfare (MHLW) in Japan approved Stivarga
(regorafenib). Stivarga is approved... Read >>